One mechanism by which mammalian cells regulate the uptake of glucose is the number of glucose transporter proteins (GLUT) present at the plasma membrane. In insulin-responsive cells types, GLUT4 is released from intracellular stores through inactivation of the Rab GTPase activating protein Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4) (also known as AS160). Here we describe that TBC1D4 forms a protein complex with protein kinase WNK1 in human embryonic kidney (HEK293) cells. We show that WNK1 phosphorylates TBC1D4 in vitro and that the expression levels of WNK1 in these cells regulate surface expression of the constitutive glucose transporter GLUT1. WNK1 was found to increase the binding of TBC1D4 to regulatory 14-3-3 proteins while reducing its interaction with the exocytic small GTPase Rab8A. These effects were dependent on the catalytic activity because expression of a kinase-dead WNK1 mutant had no effect on binding of 14-3-3 and Rab8A, or on surface GLUT1 levels. Together, the data describe a pathway regulating constitutive glucose uptake via GLUT1, the expression level of which is related to several human diseases.WNK1 is one of four human members of the WNK 2 subfamily of serine/threonine protein kinases (1) and is the only family member with a ubiquitous expression pattern (1-4). The WNK1 protein contains 2382 amino acids with a predicted molecular mass of 251 kDa and has its catalytic domain near the N terminus, including the unique sequence variation around catalytically important lysine residues that characterize the WNK subfamily (5, 6). WNK1 contains coiled-coil domains but the bulk sequence reveals no homology to other known protein domains.Currently, the knowledge on WNK1-regulated cellular pathways is still limited (7). On the one hand, WNK1 can affect multiple signaling pathways related to cell proliferation, including the epidermal growth factor-dependent stimulation of ERK5 (8) and the inhibition of Smad2/TGF signaling (9) in HeLa cells. Additionally, insulin-like growth factor 1 treatment of human embryonic kidney (HEK293) cells or adipocytes stimulates protein kinase AKT to phosphorylate WNK1 at threonine residue 60, however, the physiological relevance of this event is unclear because phosphorylation did not affect WNK1 kinase activity, or its subcellular localization (10 -12). On the other hand, WNK1 is involved in restoring osmotic homeostasis. It directly phosphorylates and activates SPAK and OSR1 protein kinases, which interact with and stimulate the activity of the cation chloride co-transporters NKCC1 (13-16) or NCC (14, 17) in HEK293 or HeLa cells. The expression of WNK1 appears also to be part of a pathway involved in inhibitory phosphorylation events of co-transporter KCC (18).Mutations in the WNK1 and WNK4 genes have been linked to pseudo-hypoaldosteronism type II (or Gordon's syndrome), a rare familial form of hypertension (2), which is characterized by increased renal salt reabsorption and decreased potassium secretion. The identified WNK1 mutations increase WNK1 expre...